{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T06:12:20Z","timestamp":1791094340895,"version":"4.1.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2001,10,1]],"date-time":"2001-10-01T00:00:00Z","timestamp":1001894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Nitric oxide metabolism is altered during the acute chest syndrome of sickle cell disease. In the presence of oxygen and oxygen-related molecules, nitric oxide can preferentially form the powerful oxidants nitrite, nitrate, and peroxynitrite. We hypothesized that increased oxidative stress may contribute to the pathogenesis of acute chest syndrome and measured F2 isoprostanes, a nonenzymatically generated molecule resulting from free radical catalyzed lipid peroxidation in patients with sickle cell disease in various stages of disease. Plasma samples were obtained from nineteen patients with sickle cell disease during acute chest syndrome (pre- and postexchange transfusion), vasoocclusive crisis, and\/or at baseline; 12 normal volunteers served as controls. F2 isoprostanes were measured by gas chromatography\/mass spectrophotometry. There was a 9-fold increase in F2 isoprostanes in patients with acute chest syndrome as compared with normal volunteers. There was approximately a 50\u201360% decline in isoprostanes postexchange transfusion to a level similar to that of patients with sickle cell disease at baseline. There was no difference in isoprostanes between vasoocclusive crisis and patients with sickle cell disease at baseline. Increased oxidative stress, measured by generation of F2 isoprostanes, occurs during acute chest syndrome and may have an important role in the pathogenesis of this disease process.<\/jats:p>","DOI":"10.1164\/ajrccm.164.7.2101020","type":"journal-article","created":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T14:54:06Z","timestamp":1365087246000},"page":"1248-1252","source":"Crossref","is-referenced-by-count":42,"title":["Increased F2 Isoprostanes in the Acute Chest Syndrome of Sickle Cell Disease as a Marker of Oxidative Stress"],"prefix":"10.1093","volume":"164","author":[{"given":"ELIZABETH S.","family":"KLINGS","sequence":"first","affiliation":[{"name":"The Pulmonary Center, Department of Surgical Research, Department of Hematology\/Oncology, Boston University School of Medicine, Boston, Massachusetts; and Department of Pulmonary\/Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BRIAN W.","family":"CHRISTMAN","sequence":"additional","affiliation":[{"name":"The Pulmonary Center, Department of Surgical Research, Department of Hematology\/Oncology, Boston University School of Medicine, Boston, Massachusetts; and Department of Pulmonary\/Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JAMES","family":"McCLUNG","sequence":"additional","affiliation":[{"name":"The Pulmonary Center, Department of Surgical Research, Department of Hematology\/Oncology, Boston University School of Medicine, Boston, Massachusetts; and Department of Pulmonary\/Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ARTHUR F.","family":"STUCCHI","sequence":"additional","affiliation":[{"name":"The Pulmonary Center, Department of Surgical Research, Department of Hematology\/Oncology, Boston University School of Medicine, Boston, Massachusetts; and Department of Pulmonary\/Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LILLIAN","family":"McMAHON","sequence":"additional","affiliation":[{"name":"The Pulmonary Center, Department of Surgical Research, Department of Hematology\/Oncology, Boston University School of Medicine, Boston, Massachusetts; and Department of Pulmonary\/Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MARC","family":"BRAUER","sequence":"additional","affiliation":[{"name":"The Pulmonary Center, Department of Surgical Research, Department of Hematology\/Oncology, Boston University School of Medicine, Boston, Massachusetts; and Department of Pulmonary\/Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HARRISON W.","family":"FARBER","sequence":"additional","affiliation":[{"name":"The Pulmonary Center, Department of Surgical Research, Department of Hematology\/Oncology, Boston University School of Medicine, Boston, Massachusetts; and Department of Pulmonary\/Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2001,10,1]]},"reference":[{"key":"2026032708080843800_B1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1055\/s-2007-1012716","article-title":"Pulmonary complications of sickle cell disease.","volume":"9","author":"Johnson","year":"1988","journal-title":"Semin Respir Med"},{"key":"2026032708080843800_B2","first-page":"6","article-title":"Pulmonary complications in adults with sickle cell disease.","volume":"6","author":"Kirkpatrick","year":"1989","journal-title":"Pulmon Perspect"},{"key":"2026032708080843800_B3","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJM200006223422502","article-title":"Causes and outcomes of the acute chest syndrome in sickle cell disease.","volume":"342","author":"Vichinsky","year":"2000","journal-title":"N Engl J Med"},{"key":"2026032708080843800_B4","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease: life expectancy and risk factors for early death.","volume":"330","author":"Platt","year":"1994","journal-title":"N Engl J Med"},{"key":"2026032708080843800_B5","first-page":"H1579","article-title":"Endothelial cell nitric oxide production in acute chest syndrome.","volume":"277","author":"Hammerman","year":"1999","journal-title":"Am J Physiol"},{"key":"2026032708080843800_B6","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1126\/science.1281928","article-title":"Biochemistry of nitric oxide and its redox\u2013activated forms.","volume":"258","author":"Stamler","year":"1992","journal-title":"Science"},{"key":"2026032708080843800_B7","doi-asserted-by":"crossref","first-page":"79S","DOI":"10.1378\/chest.105.3_Supplement.79S","article-title":"Free radical biochemistry of nitric oxide.","volume":"105","author":"Freeman","year":"1994","journal-title":"Chest"},{"key":"2026032708080843800_B8","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0024-3205(96)00651-0","article-title":"Peroxynitrite: a two-faced metabolite of nitric oxide.","volume":"60","author":"Muijsers","year":"1997","journal-title":"Life Sci"},{"key":"2026032708080843800_B9","doi-asserted-by":"crossref","first-page":"29350","DOI":"10.1074\/jbc.270.49.29350","article-title":"Kinetic analysis of the fate of nitric oxide synthesized by macrophages in vitro.","volume":"270","author":"Lewis","year":"1995","journal-title":"J Biol Chem"},{"key":"2026032708080843800_B10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1096\/fasebj.2.3.3350236","article-title":"Altered amount and activity of superoxide dismutase in sickle cell anemia.","volume":"2","author":"Schacter","year":"1988","journal-title":"FASEB J"},{"key":"2026032708080843800_B11","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/320454a0","article-title":"Superoxide anion is involved in the breakdown of endothelial derived relaxing factor.","volume":"320","author":"Gryglewski","year":"1986","journal-title":"Nature"},{"key":"2026032708080843800_B12","first-page":"129","article-title":"The measurement and mechanism of lipid peroxidation in biological systems.","volume":"15","author":"Gutteridge","year":"1990","journal-title":"TOBS"},{"key":"2026032708080843800_B13","doi-asserted-by":"crossref","first-page":"9383","DOI":"10.1073\/pnas.87.23.9383","article-title":"A series of prostaglandin F2-like compounds are produced in vivo by a non-cyclooxygenase, free radical catalyzed mechanism.","volume":"87","author":"Morrow","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026032708080843800_B14","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1172\/JCI116143","article-title":"Formation of novel non-cyclooxygenase-derived prostanoids (F2 isoprostanes) in carbon tetrachloride hepatotoxicity.","volume":"90","author":"Morrow","year":"1992","journal-title":"J Clin Invest"},{"key":"2026032708080843800_B15","doi-asserted-by":"crossref","first-page":"10721","DOI":"10.1073\/pnas.89.22.10721","article-title":"Non-cyclooxygenase-derived prostanoids (F2 isoprostanes) are formed in situ on phospholipids.","volume":"89","author":"Morrow","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026032708080843800_B16","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1172\/JCI117107","article-title":"Formation of non-cyclooxygenase-derived prostanoids (F2 isoprostanes) in plasma and low density lipoprotein exposed to oxidative stress in vitro.","volume":"93","author":"Lynch","year":"1994","journal-title":"J Clin Invest"},{"key":"2026032708080843800_B17","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1161\/01.ATV.17.11.2309","article-title":"Isoprostanes: potential markers of oxidant stress in atherothrombotic disease.","volume":"17","author":"Patrono","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026032708080843800_B18","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1172\/JCI119735","article-title":"Localization of distinct F2 isoprostanes in human atherosclerotic lesions.","volume":"100","author":"Pratico","year":"1997","journal-title":"J Clin Invest"},{"key":"2026032708080843800_B19","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJM199505043321804","article-title":"Increase in circulating products of lipid peroxidation (F2 isoprostanes) in smokers: smoking as a cause of oxidative damage.","volume":"332","author":"Morrow","year":"1995","journal-title":"N Engl J Med"},{"key":"2026032708080843800_B20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0014-5793(95)00649-T","article-title":"Plasma 8-epi-PGF2 alpha levels are elevated in individuals with non-insulin dependent diabetes mellitus.","volume":"368","author":"Gopaul","year":"1995","journal-title":"FEBS Lett"},{"key":"2026032708080843800_B21","first-page":"3727","article-title":"Elevated levels of 8- epi-PGF2\u03b1 in familial hypercholesterolemia: evidence of oxidative stress in vivo.","volume":"94","author":"Reilly","year":"1996","journal-title":"Circulation"},{"key":"2026032708080843800_B22","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0003-9861(91)90224-7","article-title":"Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide.","volume":"288","author":"Radi","year":"1991","journal-title":"Arch Biochem Biophys"},{"key":"2026032708080843800_B23","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1164\/ajrccm.156.1.9611085","article-title":"Endothelin-1 production during the acute chest syndrome in sickle cell disease.","volume":"156","author":"Hammerman","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032708080843800_B24","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0891-5849(98)00152-X","article-title":"F2 isoprostanes generation in isolated ferret lungs after oxidant injury or ventilated ischemia.","volume":"25","author":"Becker","year":"1998","journal-title":"Free Rad Biol Med"},{"key":"2026032708080843800_B25","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1365-2141.1995.tb05397.x","article-title":"The metabolites of nitric oxide in sickle cell disease.","volume":"95","author":"Rees","year":"1995","journal-title":"Br J Hematology"},{"key":"2026032708080843800_B26","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.1182\/blood.V89.12.4591","article-title":"Mechanisms of stroke in sickle cell disease: sickle erythrocytes decrease cerebral blood flow in rats after nitric oxide synthase inhibition.","volume":"89","author":"French","year":"1997","journal-title":"Blood"},{"key":"2026032708080843800_B27","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/0002-8703(93)91049-K","article-title":"Inhibition of endothelium dependent vasorelaxation by sickle erythrocytes.","volume":"126","author":"Mosseri","year":"1993","journal-title":"Am Heart J"},{"key":"2026032708080843800_B28","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1172\/JCI9225","article-title":"Hypoxia\/reoxygenation causes inflammatory response in transgenic sickle cell mice but not in normal mice.","volume":"106","author":"Kaul","year":"2000","journal-title":"J Clin Invest"},{"key":"2026032708080843800_B29","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0891-5849(98)00196-8","article-title":"Biomarkers of free radical damage: applications in experimental animals and humans.","volume":"26","author":"De Zwart","year":"1999","journal-title":"Free Rad Biol Med"},{"key":"2026032708080843800_B30"},{"key":"2026032708080843800_B31","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1161\/01.ATV.18.8.1248","article-title":"The F2 isoprostane 8-epi-prostaglandin F2\u03b1 increases platelet adhesion and reduces the anti-adhesive and anti-aggregatory effects of NO.","volume":"18","author":"Minuz","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026032708080843800_B32","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1056\/NEJM199904013401307","article-title":"Management of sickle cell disease.","volume":"340","author":"Steinberg","year":"1999","journal-title":"N Engl J Med"},{"key":"2026032708080843800_B33","first-page":"210","article-title":"Release of prostacyclin after erythrocyte adhesion to cultured vascular endothelium.","volume":"107","author":"Wautier","year":"1986","journal-title":"J Lab Clin Med"},{"key":"2026032708080843800_B34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00000441-199001000-00004","article-title":"Low plasma pre-albumin and carotenoid levels in sickle cell disease patients.","volume":"299","author":"Jain","year":"1990","journal-title":"Am J Med Sci"},{"key":"2026032708080843800_B35","first-page":"720","article-title":"Serum vitamin E and the sickling status in children with sickle cell anaemia.","volume":"67","author":"Ndombi","year":"1990","journal-title":"East African Med J"},{"key":"2026032708080843800_B36","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ajh.2830410402","article-title":"Relationship of plasma alpha tocopherol to index of clinical severity in individuals with sickle cell anemia.","volume":"41","author":"Phillips","year":"1992","journal-title":"Am J Hematol"},{"key":"2026032708080843800_B37","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/ajcn\/33.5.968","article-title":"A decrease in irreversibly sickled erythrocytes in sickle cell anemia patients given vitamin E.","volume":"33","author":"Natta","year":"1980","journal-title":"Am J Clin Nutr"},{"key":"2026032708080843800_B38","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3109\/10715769609149918","article-title":"Antioxidant status and susceptibility of sickle erythrocytes to oxidative and osmotic stress.","volume":"25","author":"Tatum","year":"1996","journal-title":"Free Rad Res"},{"key":"2026032708080843800_B39","first-page":"48","article-title":"Plasma levels of retinol, ascorbic acid, and alpha-tocopherol in sickle cell anemia.","volume":"41","author":"Essien","year":"1995","journal-title":"Central African J Med"},{"key":"2026032708080843800_B40","first-page":"683","article-title":"Ascorbic acid in sickle cell disease: results of a pilot therapeutic trial.","volume":"60","author":"Akinkugbe","year":"1983","journal-title":"E African Med J"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/164\/7\/1248\/67580879\/ajrccm_164_7_1248.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/164\/7\/1248\/67580879\/ajrccm_164_7_1248.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T12:08:18Z","timestamp":1774613298000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/164\/7\/1248\/8544645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,10,1]]},"references-count":40,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2001,10,1]]},"published-print":{"date-parts":[[2001,10,1]]}},"URL":"https:\/\/doi.org\/10.1164\/ajrccm.164.7.2101020","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2001,10]]},"published":{"date-parts":[[2001,10,1]]}}}